EXECUTIVE AGREEMENT ThisExecutiveAgreement(Agreement),effectiveJanuary1,2018,isexecutedonJanuary20, 2019,byandbetweenParallaxHealthSciences,Inc.,aNevadacorporation,(theCompany),and MJManagementServices,Inc.,aDelawarecorporation,1702DelawareAvenue,SantaMonica,CA 90404(MJManagement),forservicesprovidedbyCalliR.Bucci(theExecutive),hereinafter, collectively, the Parties. WITNESSETH: WHEREAS,theCompanyisengagedinthemedicaldiagnosticstechnology,behavioralhealthand relatedbusinesses,includingbutnotlimitedtohardwareandsoftwaredevelopmentandsalesfor healthcare,    and    information    technology    (the    Technologies);    and    conducts    research, experimentation,development,andexploitationofrelatedtechnologiesandengagesinother businesses; and WHEREAS,ExecutivehasprovidedservicesasChiefFinancialOfficeroftheCompanysince November 2012, and has served as a member of the board of directors since December 2016; and WHEREAS,theCompanydesirestocontinuetohaveExecutiveprovideservicesasChief FinancialOfficeroftheCompany,andExecutivedesirestoprovideservicestotheCompanyin such capacities pursuant to the terms and conditions hereinafter set forth. NOWTHEREFORE,inconsiderationoftheforegoingandthemutualpromisesandcovenants herein contained, it is agreed as follows: 1.DUTIES AND RESPONSIBILITIES a.The  Company  hereby  retains  the  services  of  Executive  in  the  role  ofChief  Financial Officer of the Company.  Subject at all times to the direction of the Board of Directors and theChiefExecutiveOfficerandPresidentoftheCompany,Executiveshallhavedirect responsibility  over  financial  accounting  and  SEC  reporting,  operational  budgeting,  sales costinganalysis,billing,andauditorinterfacing.Executivewillalsoperformotherservices and duties as the Board of Directors and/or the Chief Executive Officer shall determine. b.   ExecutivecurrentlyholdsthepositionofSecretaryandTreasureroftheCompany. Executiveshallserve,bymutualconsent,intheseorsuchotherpositionsandofficesofthe Company  and  its  affiliates,  if  selected,  without  any  additional  compensation,  except  in connection with paragraph 1.c, and as set forth in paragraph 5.a.iii. c.The Parties acknowledge that, for various reasons discussed between the parties, a change in theExecutivesroleofChiefFinancialOfficermayberequiredbyeitherpartyinthefuture. In  this  event,  Executive  shall,  by  mutual  consent,  continue  to  provide  services  to  the Companyinaconsultantcapacitytobefurtherdefined,theprovisionsofwhichare consistent with the terms and conditions set forth in this Agreement, unless otherwise clearly defined.  2.PERFORMANCE ExecutiveherebyacceptsthepositionofferedbytheCompany,uponthetermsandconditions contained herein, and agrees that during the Term of this Agreement, as defined in section 4, the Executive,asChiefFinancialOfficer,shalldevotesubstantiallyallofherbusinesstime, attention,andenergiestothebusinessoftheCompany,withanaverageminimumofforty(40) hoursperweek.ExecutivesdutiesshallbeperformedatExecutiveshomeofficelocatedin SantaMonica,California,or,whenrequired,sheshallbepresentontheCompanyspremises locatedinSantaMonica,California,andengagedinservicetooronbehalfoftheCompanyat such times, except during vacations, regular business holidays or weekends. DuringtheTermofthisAgreement,asdefinedinsection4,Executivewillnotperformany servicesforanyotherbusinessentity,whethersuchentityconductsabusinesswhichis competitivewiththebusinessoftheCompanyorisengagedinanyotherbusinessactivity; provided,however,thatnothinghereincontainedshallbeconstruedas(a)preventingExecutive frominvestingherpersonalassetsinanybusinessorbusinesseswhichdonotcompetedirectly orindirectlywiththeCompany,providedsuchinvestmentorinvestmentsdonotrequireany services on her part in the operation of the affairs of the entity in which such investment is made and  in  which  her  participation  is  solely  that  of  an  investor,  (b)  preventing  Executive  from purchasingsecuritiesinanycorporationwhosesecuritiesareregularlytraded,ifsuchpurchases shallnotresultinherowningbeneficially,atanytime,morethan5%oftheequitysecuritiesof anycorporationengagedinabusinesswhichiscompetitive,directlyorindirectly,tothatofthe Company,(c)preventingExecutivefromengaginginanyotheractivities,ifshereceivesthe prior written approval of the Board of Directors of the Company with respect to her engaging in suchactivities;withexceptiontoherroleasChiefFinancialOfficeroftheCompanyswholly ownedsubsidiariesandanyofficialpositionExecutivemayholdwithPearTrackSecurity Systems, Inc. and its subsidiaries. 3.RECORDS Inconnectionwithherengagementhereunder,Executiveshallaccuratelymaintainandpreserve allnotesandrecordsgeneratedbytheCompanywhichrelatetotheCompanyanditsbusiness and shall make all such reports, written if required, as the Company may reasonably require. 4.TERM TheinitialtermofthisAgreementshallbeforonetwelve-monthperiod(theInitialTerm),to commence  on  January  1,  2018,  and  end  twelve  months  from  the  date  of  this  Agreement. Thereafter,theAgreementshallautomaticallybeextendedforsuccessivetwelve-monthperiods (theSubsequentTerm(s)),unlesseitherpartyelectsnottorenewthisAgreementforanyyear byprovidingwrittennoticeaminimumofthirty(30)dayspriortotheendofthemostrecent twelve-monthperiod.IftheExecutiveisnotretainedforaSubsequentTerm,theExecutive shall have the right to a one-year severance agreement (Severance Period) at the prevailing rate ofcompensation(SeverancePay).Atwelve-monthperiodshallbedeemedaContractYear. ForthepurposesofthisAgreement,theTerm(theTerm)shallbedefinedastheInitialTerm andanySubsequentTerm(s),collectively.Non-renewaloftheAgreementbytheCompanyshall bedeemedaterminationpursuanttoSection15.a.Forallcompensationandbenefitpurposes, otherthanthosespecificallyaddressedherein,theExecutiveshallbedeemedtohavebeen   Parallax Health Sciences, Inc. Executive Agreement  Calli R. Bucci Page 1 of 10


continually employed with the Company under this Agreement from January 1, 2018. 5.COMPENSATION AsfullcompensationfortheperformanceofherdutiesonbehalfoftheCompany,Executive shall be compensated as follows: a.Base Compensation The Company shall pay the Executive: i.whileholdingtheroleofChiefFinancialOfficer,aBaseCompensation(Base Compensation)  at  the  rate  of  Two  Hundred  Sixteen  Thousand  Dollars  ($216,000) duringthefirst-yearoftheInitialTermhereof;payablemonthlybythe5thdayofeach month. ii.IfthisAgreementisrenewedforSubsequentTerm(s),theExecutivesBase Compensation as Chief Financial Officer shall be increased pursuant to a) a minimum of Ten-Percent(10%)peryear(theMinimumIncrease),orb)astheBoardofDirectors shalldetermineifinexcesstotheMinimumIncrease.   FutureCompensationincreases will be subject to mutual agreement in accordance with job performance. iii.IfExecutiveleavestheroleofChiefFinancialOfficerinaccordancewithparagraph1.c above, but remains with the Company in a consultant capacity: A.a  minimum  retainer  of  Ten  Thousand  Dollars  ($10,000)  per  month  for  services provided, up to eighty (80) hours per month, payable monthly by the 5th day of each month; and B.$100 per hour for each additional hour above eighty (80) hours per month, but in no eventtoexceedanadditionalTenThousandDollars($10,000)permonth,fora maximumtotalmonthlycompensationofTwentyThousandDollars($20,000). Executive  shall  provide  monthly  invoices  to  the  Company  for  additional  hours worked each month, upon receipt of which the Company shall remit payment. b.   ExecutionBonusUponexecutionofthisAgreement,Executiveshallreceiveanon- refundable,fullyvestedExecutionBonusofonehundredthousanddollars($100,000)in return for Executive entering into this Agreement. c.AnnualBonus.InadditiontotheBaseCompensation,Executivewillbeeligibleforan annualperformancebonusofbetweentenpercent(10%)andtwentyfivepercent(25%)of theBaseCompensationinanygivenyear,tobepayableuponachievementofperformance goals and objectives to be mutually agreed uponbytheExecutive andtheCompanysBoard of Directors in advance of the relevant performance period. d.Other  Meritorious  Adjustments.  The  Board  of  Directors  may,  in  their  sole  discretion, consider  other  meritorious  adjustments  in  compensation,  or  a  bonus,  under  appropriate circumstances,includingtheconceptionofvaluableoruniqueinventions,processes, discoveries or improvements capable of profitable exploitation.   Parallax Health Sciences, Inc. Executive Agreement  Calli R. Bucci Page 1 of 10  e.Payment    All  cash  payments  to  Executive  under  this  Agreement  shall  be  made  to  MJ Management Services, Inc., its heirs, successors or assigns. 6.EQUITY a.IncentiveStockOptions.ExecutivemaybegrantedstockoptionsduringtheTermofthis AgreementasdeterminedbytheCompanysBoardofDirectorsfromtimetotime,subject tosubsections6.cand6.dbelow.Executiveshallbegrantedthefollowinginitialstock options upon execution of this Agreement: i.1,000,000sharesoftheCompanyscommonstockatanexercisepriceof$0.25per share.Theoptionsshallbeexercisableforaperiodoffive(5)years,shallvestquarterly over the Initial Term of the Agreement, and are subject to subsections 6.d and 6.e below. ii.IntheeventthisAgreementisrenewedforSubsequentTerm(s),Executiveshallbe grantedoptionstopurchase1,000,000sharesoftheCompanyscommonstockatan exercise  price  of  the  average  market  price  of  the  Companys  common  stock  over  a period of thirty (30) days prior to the date of the grant, for each additional Contract Year ofthisAgreement.Theoptionsshallbeexercisableforaperiodoffive(5)years,shall vestquarterlyovereachadditionalContractYear,andaresubjecttosubsections6.dand 6.e below. b.   10b5-1TradingPlansWhenanaveragefive(5)daytradingofPRLXcommonstockis greater than 100,000 shares per day, the Company intends on instituting trading plans, which will, among other things, restrict Executive from trading more than 10,000 shares per day or selling more than $100,000 in any given month. c.Change of Control.  In the event of a merger, acquisition or sale transaction by the Company which  causes  a  Change  of  Control  of  the  Company  (the  Control  Change),  any  stock options,stockgrantoraward,orsimilarsecuritiesheldbeneficiallybytheExecutiveshall automaticallybecomefullyvested.   ForpurposesofthisSection6.e,ControlChangeshall mean the occurrence of any of the following events: i.amajorityoftheoutstandingvotingstockoftheCompanyisacquiredorbeneficially ownedbyanyperson(otherthantheCompanyorasubsidiaryoftheCompany)orany twoormorepersonsactingasapartnership,limitedpartnership,syndicateorother group,  entity  or  association  acting  in  concert  for  the  purpose  of  voting,  acquiring, holding, or disposing of voting stock of the Company; or ii.amergeroraconsolidationoftheCompanywithorintoanothercorporation,other than: A.a merger or consolidation with a subsidiary of the Company, or B.amergerorconsolidationinwhichtheholdersofvotingstockoftheCompany immediately prior to the merger as a class hold immediately after the merger at least a majorityofalloutstandingvotingpowerofthesurvivingorresultingcorporationor its parent; or   Parallax Health Sciences, Inc. Executive Agreement  Calli R. Bucci Page 1 of 10


iii.astatutoryexchangeofsharesofoneormoreclassesorseriesofoutstandingvoting stockoftheCompanyforcash,securities,orotherproperty,otherthananexchangein whichtheholdersofvotingstockoftheCompanyimmediatelypriortotheexchangeas aclassholdimmediatelyaftertheexchangeatleastamajorityofalloutstandingvoting power of the entity with which the Company stock is being exchanged; or iv.thesaleorotherdispositionofallorsubstantiallyalloftheassetsoftheCompany,in onetransactionoraseriesoftransactions,otherthanasaleordispositioninwhichthe holdersofvotingstockoftheCompanyimmediatelypriortothesaleordispositionasa classholdimmediatelyaftertheexchangeatleastamajorityofalloutstandingvoting power of the entity to which the assets of the Company are being sold. 7.BUSINESS EXPENSES The Company also shall reimburse the Executive for all business expenses incurred by Executive intheperformanceofherdutieshereunder,oradvanced/paidbyExecutiveonbehalfofthe Company,including,butnotlimitedto,travelonbusiness,attendingtechnicalandbusiness meetings,professionalactivities,andcustomerentertainment,suchreimbursementtobemade in accordance with regular Company policy and within a reasonable period following Executives presentation of the details of, and proof of, such expenses. 8.FRINGE BENEFITS a.DuringtheTermofthisAgreement,theExecutiveshallbeentitledtoreceivefromthe Company up to $5,000 for the initial lease of a vehicle, and a vehicle allowance of $1,000 per monththereafter,subjecttofutureincreasesasmaybegrantedtootherseniorexecutives. TheCompanyshallpayfororreimburseExecutiveforexpensesregardingtheoperation, insuranceandroutinemaintenanceofsuchvehicle,includingdeductibles,fuel,parking,tolls and car washes. b.   During  the  Term  of  this  Agreement,  the  Company  shall  provide,  at  its  sole  expense, hospitalization,majormedical,lifeinsuranceandotherfringebenefitsonthesameterms andconditionsasitshallaffordotherseniormanagementExecutives.Nothinghereinshall require Executive to obtain or maintain such coverage. c.During the Term of this Agreement, the Company shall provide paid vacation, to Executive, whichaccruesfromthedateofexecutionofthisAgreement.Theannualpaidvacation earned for each Contract Year shall be calculatedonaforty(40)hourworkweekasfollows: (i) four (4) weeks per Contract Year for the first two (2) Contract Years; (ii) six (6) weeks per ContractYearformorethantwo(2)anduptoseven(7)ContractYears;and(iii)eight(8) weeks per Contract Year for more than seven (7) Contact Years. 9.SUBSIDIARIES For the purposes of this Agreement all referencesto business products, services and sales of the Company shall include those of the Companys affiliates.   Parallax Health Sciences, Inc. Executive Agreement  Calli R. Bucci Page 1 of 10  10.INVENTORIES: SHOP RIGHTS a.All systems, inventions, discoveries, apparatus, techniques, methods, know-how, formulae or improvementsmade,developedorconceivedbyExecutiveduringtheTermofthis Agreement  ,  whenever  or  wherever  made,  developedorconceived,and  whetheror  not during business hours, which constitute an improvement, on those heretofore, now or at any during  Executives  employment,  developed,  manufactured  or  used  by  the  Company  in connection with the manufacture, process or marketing of any product heretofore or now or hereafterdevelopedordistributedbytheCompany,oranyservicestobeperformedbythe Companyorofanyproductwhichshallorcouldreasonablybemanufacturedordeveloped ormarketedinthereasonableexpansionoftheCompanysbusiness,shallbeandcontinue to  remain  the  Companys  exclusive  property,  without  any  added  compensation  or  any reimbursementforexpensestoExecutive,andupontheconceptionofanyandeverysuch invention,process,discoveryorimprovementandwithoutwaitingtoperfectorcompleteit, ExecutivepromisesandagreesthatExecutivewillimmediatelydiscloseittotheCompany and to no one else and thenceforth will treat it as the property and secret of the Company. b.   ExecutivewillalsoexecuteanyinstrumentsrequestedfromtimetotimebytheCompanyto vest in it complete title and ownership to such invention, discovery or improvement and will, attherequestoftheCompany,dosuchactsandexecutesuchinstrumentastheCompany may  require,  but  at  the  Companys  expense  to  obtain  Letters  of  Patent,  trademarks  or copyrights  in  the  United  States  and  foreign  countries,  for  such  invention,  discovery  or improvementandforthepurposeofvestingtitletheretointheCompany,allwithoutany reimbursementforexpenses(exceptasprovidedinSection7orotherwise)andwithoutany additional compensation of any kind to Executive. 11.CONFIDENTIAL INFORMATION and TRADE SECRETS a.All Confidential Information shall be the sole property of the Company.Executive will not, duringtheperiodofheremploymentandforaperiodendingtwoyearsafterterminationof heremploymentforanyreason,disclosetoanypersonorentityoruseorotherwiseexploit for Executives own benefit or for the benefit of any other person or entity any Confidential InformationwhichisdisclosedtoExecutiveorwhichbecomesknowntoExecutiveinthe course of her employment with the Company without the prior written consent of an officer of  the  Company  except  as  may  benecessaryandappropriateintheordinarycourseof performing  her  duties  to  the  Company  during  the  period  of  her  employment  with  the Company. For purposes of this Section 11.a, Confidential Information shall mean any data orinformationbelongingtotheCompany,otherthanTradeSecrets,thatisofvaluetothe Company and is not generally known to competitors of the Company or to the public, and is maintained   confidential   by   the   Company,   including   but   not   limited   to   non-public informationabouttheCompanysclients,executives,keycontractorsandothercontractors andinformationwithrespecttoitsproducts,designs,services,strategies,pricing,processes, procedures,research,development,inventions,improvements,purchasing,accounting, engineeringandmarketing(includinganydiscussionsornegotiationswithanythirdparties). Notwithstanding   the   foregoing,   no   information   will   be   deemed   to   be   Confidential Information unless such information is treated by the Company as confidential and shall not includeanydataorinformationoftheCompanythathasbeenvoluntarilydisclosedtothe publicbytheCompany(exceptwheresuchpublicdisclosurehasbeenmadewithoutthe   Parallax Health Sciences, Inc. Executive Agreement  Calli R. Bucci Page 1 of 10  authorizationoftheCompany),orthathasbeenindependentlydevelopedanddisclosedby others, or that otherwise enters the public domain through lawful means. b.   AllTradeSecretsshallbethesolepropertyoftheCompany.Executiveagreesthatduring heremploymentwiththeCompanyandafteritstermination,Executivewillkeepin confidence and trust and will not use or disclose any Trade Secret or anything relating to any TradeSecret,ordeliveranyTradeSecret,toanypersonorentityoutsidetheCompany withoutthepriorwrittenconsentofanofficeroftheCompany.Forpurposesofthis Section11.b,TradeSecretsshallmeananyscientific,technicalandnon-technicaldata, information,formula,pattern,compilation,program,device,method,technique,drawing, process,financialdata,financialplan,product planorlistofactualorpotentialcustomersor vendors  and  suppliers  of  the  Company  or  any  portion  or  part  thereof,  whether  or  not copyrightableorpatentable,thatisofvaluetotheCompanyandisnotgenerallyknownto competitors  of  the  Company  or  to  the  public,  and  whose  confidentiality  is  maintained, includingunpatentedandun-copyrightedinformationrelatingtotheCompanysproducts, informationconcerningproposednewproductsorservices,marketfeasibilitystudies, proposedorexistingmarketingtechniquesorplansandcustomerconsumptiondata,usage orloaddata,andanyotherinformationthatconstitutesatradesecret,assuchtermas defined  in  the  Official  Code  of  Nevada  Annotated,  in  each  case  to  the  extent  that  the Company,asthecontextrequires,deriveseconomicvalue,actualorpotential,fromsuch informationnotbeinggenerallyknownto,andnotbeingreadilyascertainablebyproper meansby,otherpersonsorentitieswhocanobtaineconomicvaluefromitsdisclosureor use. 12.NON-SOLICITATION OF EXECUTIVES DuringtheTermofthisAgreementandforoneyearthereafter,Executivewillnotcauseor attempttocauseanyExecutiveoftheCompanytoceaseworkingfortheCompanytoretain employmentwithanotherCompanythatisacompetitoroftheCompanys.However,this obligationshallnotaffectanyresponsibilityExecutivemayhaveasanExecutiveofthe Company with respect to the bona fide hiring and firing of the Companys personnel. 13.NON-SOLICITATION OF CUSTOMERS AND PROSPECTIVE CUSTOMERS Executivewillnot,duringtheperiodofheremploymentandforaperiodendingtwo(2)years after the termination of her employment for any reason, directly or indirectly, solicit the business of  any  customer  for  the  purpose  of,  or  with  the  intention  of,  selling  or  providing  to  such customeranyproductorserviceincompetitionwithanyproductorservicesoldorprovidedby the  Companyduring  the  twelve  (12)  monthsimmediately  preceding  the  termination  of  this Agreement with the Company. 14.NON-COMPETITION ExecutiveagreesthatduringheremploymentwiththeCompany,Executivewillnotengagein any  employment,  business,  or  activity  that  is  in  any  way  competitive  with  the  business  or proposedbusinessoftheCompany,andExecutivewillnotassistanyotherpersonor organizationincompetingwiththeCompanyorinpreparingtoengageincompetitionwiththe businessorproposedbusinessoftheCompany.Theprovisionsofthisparagraphshallapply   Parallax Health Sciences, Inc. Executive Agreement  Calli R. Bucci Page 1 of 10


bothduringnormalworkinghoursandatallothertimesincluding,withoutlimitation,nights, weekends and vacation time, while Executive is employed with the Company. 15.TERMINATION Executives position with the Company may be terminated as follows: a.Termination Without Just Cause. i.The  Company,  in  its  sole  discretion,  may  terminate  this  Agreement  for  any  reason withoutJustCause(asdefinedbelow),atanytime,bygivingwrittennoticetoExecutive ofsuchintentatleastthirty(30)daysinadvanceoftheeffectivedateoftermination; provided, during all that thirty (30) day notice period, the Company, in its sole discretion, may modify, reduce or eliminate Executives duties hereunder. ii.IftheCompanyterminatesthisAgreementhereunderwithoutJustCausetheCompany shallcontinuetopaytoExecutiveherthen-currentBaseCompensation,plusaccrued butunpaidvacationtime,accruedbutunpaidbenefits,andreimbursementofallunpaid businessexpenses(ineachcase,asofthedateoftermination)(collectivelythe ContinuedBenefits)foraperiodofthegreaterof(a)twelve(12)months;or(b)the remainderoftheInitialTermorSubsequentTerm,whicheverthecasemaybe(the ContinuationPeriod).Executiveshallbeentitledtocontinuedparticipationinall medical and disability plans, to the extent such plans are provided by the Company at the dateoftermination,atthesamebenefitlevelatwhichshewasparticipatingonthedate of termination of this Agreement until the expiration of the Continuation Period. b.   Termination With Just Cause. i.TheCompanymayimmediatelyterminatethisAgreementhereunderforJustCause(as definedbelow)atanytimeupondeliveryofwrittennoticetoExecutive.Forpurposes of this Agreement, the phrase Just Cause means: A.Executives material fraud, gross malfeasance, gross negligence, or willful misconduct done in bad faith, with respect to the Companys business affairs; B.Executives   refusal   or   repeated   failure   to   follow   the   Companys   established reasonable and lawful policies of the Company; C.Executives material breach of this Agreement; or D.  Executives conviction of a felony or crime involving moral turpitude. ii.AterminationofExecutiveforJustCausebasedonclauseA,BorCofthepreceding sentencewilltakeeffectthirty(30)daysafterExecutivereceivesfromtheCompany writtennoticeofitsintenttoterminatethisAgreementandtheCompanysdescription of the alleged cause, unless Executive, in the good-faith opinion of the Company, during such 30-day period, remedies the events or circumstances constituting Just Cause.   Parallax Health Sciences, Inc. Executive Agreement  Calli R. Bucci Page 1 of 10  iii.If this Agreement hereunder is terminated by the Company for Just Cause, the Company will  be  required  to  pay  to  Executive  only  that  portion  of  her  Base  Compensation, accruedvacation,andtotheextentrequiredunderthetermsofanybenefitplanorthis Agreement,thevestedportionofanybenefitundersuchplan,allasearnedthroughthe date of termination. c.Termination For Good Reason. i.ExecutivemayterminateemploymenthereunderForGoodReason(asdefinedbelow), atanytime,bygivingwrittennoticetotheCompanyofsuchintentatleastthirty(30) days in advance of the effective date of termination. For purposes of this Agreement, the phrase For Good Reason means: A.any reduction in duties, responsibility, position or compensation; B.the Companys material breach of this Agreement; or C.the Companys refusal or failure to establish and follow lawful policies and practices. ii.IfExecutiveterminatesemploymenthereunderForGoodReason,theCompanyshall continue  to  pay  to  Executive  the  Continued  Benefits  for  the  Continuation  Period. Executiveshallbeentitledtocontinuedparticipationinallmedicalanddisabilityplans, to the extent such plans are provided by the Company, at the same benefit level at which she was participating on the date of termination of this Agreement until the expiration of the Continuation Period. d.Termination due to Disability and Death. ThisAgreementhereunderwillbeterminatedimmediatelyuponExecutivesdisability(as determined  for  purposes  of  the  Companys  long-term  disability  plan)  or  death.    If  this Agreement is terminated due to such disability or death, the Company will be required to pay ExecutiveorExecutivesestate,asthecasemaybe,inadditiontotheamountspayable undertheCompanysshort-termandlong-termdisabilityplansorlifeinsuranceplans(as applicable),onlyherBaseCompensationandaccruedvacation,earnedthroughthedateof termination,  any  unreimbursed  business  expenses,  and  to  the  extent  required  under  the termsofanybenefitplanorthisAgreement,thevestedportionofanybenefitundersuch plan.ExecutiveorExecutivesestate,asthecasemaybe,willnotbyoperationofthis provisionforfeitanyrightsinwhichExecutiveisvestedatthetimeofExecutivesdisability or death. e.Services after Termination IntheeventthisAgreementisterminatedpursuanttoparagraphs15a,Executivewill,in goodfaith,remainavailabletotheCompanyduringtheSeverancePeriodforanyneedsthe CompanymayhaveinconnectionwiththeCompanyspendinglitigationmatters,orother mattersconcerningtheCompanyanditssubsidiaries,asreasonablyrequestedfromtimeto time.  Executive  will,  as  needed,  devote  up  to  five  (5)  hours  per  week  performing  such servicesrequestedbytheCompanyduringtheSeverancePeriodatnocosttotheCompany.   Parallax Health Sciences, Inc. Executive Agreement  Calli R. Bucci Page 1 of 10


IntheeventtheCompanydesiresExecutivetodevotetimeinexcessoffive(5)hoursper week,theCompanyshallpayExecutiveattherateof(i)$100perhourforeachhourover five(5)hoursperweekofservicesperformed;and(ii)allreasonableout-of-pocketexpenses incurredinperformingsuchservices,providedtheexpenseshavebeenapprovedbythe Companyinwritinginadvance.Forservicesprovidedunderthisparagraph,Executivewill provide the Company with a monthly invoice that will include the date(s) and hours worked, andexpensesincurred,whichshallincludecopiesofreceiptsforexpenses.   TheCompany shallremitpaymenttoExecutivewithinfifteen(15)daysofreceiptofinvoicefrom Executive.Thepartiesheretoacknowledgethatbutforthisparagraph,Executiveisnot requiredtorendertheservicesduringtheSeverancePeriod.     Innoeventshallthe ExecutivesSeverancePaybereducedforservicesprovidedbyExecutiveunderthis paragraph. 16.INDEMNIFICATION InadditiontoanyrightsExecutivemayhaveundertheCompany'scharterorby-laws,the CompanyagreestoindemnifyExecutiveandholdExecutiveharmless,bothduringtheTerm andthereafter,againstallcosts,expenses(including,withoutlimitation,fines,excisetaxesand attorneys'andaccountantsfees)andliabilities(otherthansettlementstowhichtheCompany doesnotconsent,whichconsentshallnotbeunreasonablywithheld)(collectively,"Losses") reasonablyincurredbyExecutiveinconnectionwithanyclaim,action,proceedingor investigation brought against or involving Executive with respect to, arising out of or in any way relatingtoExecutive'spositionwiththeCompanyorExecutive'sserviceasadirectorofthe Company;provided,however,thattheCompanyshallnotberequiredtoindemnifyExecutive forLossesincurredasaresultofExecutive'sintentionalmisconductorgrossnegligence(other than matterswhere Executive acted in good faith and in a manner she reasonably believed to be in  and  not  opposed  to  the  Company's  best  interests).  Executive  shall  promptly  notify  the Companyofanyclaim,action,proceedingorinvestigationunderthisparagraphandthe Companyshallbeentitledtoparticipateinthedefenseofanysuchclaim,action,proceedingor investigation and, if it so chooses, to assume the defense with counsel selected by the Company; providedthatExecutiveshallhavetherighttoemploycounseltorepresenthim(atthe Company'sexpense)ifCompanycounselwouldhavea"conflictofinterest"inrepresenting boththeCompanyandExecutive.TheCompanyshallnotsettleorcompromiseanyclaim, action,proceedingorinvestigationwithoutExecutive'sconsent,whichconsentshallnotbe unreasonablywithheld;provided,however,thatsuchconsentshallnotberequiredifthe settlemententailsonlythepaymentofmoneyandtheCompanyfullyindemnifiesExecutivein connectiontherewith.TheCompanyfurtheragreestoadvanceanyandallexpenses(including, withoutlimitation,thefeesandexpensesofcounsel)reasonablyincurredbytheExecutivein connection with any such claim, action, proceeding or investigation. If the Company maintains a policyofdirectors'andofficers'liabilityinsurance,theExecutivewillbecoveredunderthe policyand,notwithstandingtheexpirationorearlierterminationofthisAgreement,the CompanyshallmaintaincoveragefortheExecutiveforaperiodoftimefollowingsuch expirationorearlierterminationequaltothestatuteoflimitationsforanyclaimthatmaybe assertedagainstExecutiveforwhichcoverageisavailableundersuchdirectors'andofficers' liabilityinsurancepolicy.Theprovisionsofthisparagraphshallsurvivetheterminationofthis Agreement for any reason.   Parallax Health Sciences, Inc. Executive Agreement  Calli R. Bucci Page 1 of 10


17.NOTICE Anynoticerequiredorpermittedhereundershallbemadeinwriting(i)eitherbyactualdelivery of the notice into the hands of the party hereunder entitled, or (ii) by the mailing of the notice in theUnitedStatesmail,certifiedmail,returnreceiptrequested,allpostageprepaidandaddressed tothepartytowhomthenoticeistobegivenatthepartysrespectiveaddresssetforthbelow, or  such  other  address  as  the  parties  may  fromtime  to  time  designate  by  written  notice  as providedhereinand(iii)viaemailtotheemailaddressprovidedorfacsimiletothefaxnumber providedbythePartiesbelowwithaconfirmationreceipt.Noticewillherebybedeemedtobe satisfied via the delivery of any of the methods listed above. If to the Company: Parallax Health Sciences, Inc. 1327 Ocean Avenue, Suite B Santa Monica, CA 90401 If to Executive: MJ Management Services, Inc. 1702 Delaware Avenue Santa Monica, CA 90404 mjmgmt@roadrunner.com Thenoticeshallbedeemedtobereceivedincase(i)onthedateofactualreceiptbytheparty and in case (ii) three days following the date of the mailing. 18.INJUNCTION a.ShouldExecutiveatanytimereveal,orthreatentoreveal,anysuchsecretknowledgeor information, or during any restricted period engage, or threaten to engage, in any business in competitionwiththatoftheCompany,orperform,orthreatentoperform,anyservicesfor anyoneengagedinsuchcompetitivebusiness,orinanywayviolate,orthreatentoviolate, anyoftheprovisionsofthisAgreement,theCompanyshallbeentitledtoaninjunction restrainingExecutivefromdoing,orcontinuingtodo,orperforminganysuchacts;and Executive hereby consents to the issuance of such an injunction. b.   In  the  event  that  a  proceeding  is  brought  in  equity  to  enforce  the  provisions  of  this Paragraph,Executiveshallnotargueasadefensethatthereisanadequateremedyatlaw, nor  shall  the  Company  be  prevented  from  seeking  any  other  remedies  which  may  be available. c.TheexistenceofanyclaimorcauseofactionbytheCompanyagainstExecutive,orby Executive against the Company, whether predicated upon this Agreement or otherwise, shall notconstituteadefensetotheenforcementbytheCompanyoftheforegoingrestrictive covenants but shall be litigated separately.   Parallax Health Sciences, Inc. Executive Agreement  Calli R. Bucci Page 1 of 10  19.ARBITRATION a.Intheeventthatthereshallbeadispute(aDispute)amongthepartiesarisingoutofor relatingtothisAgreement,orthebreachthereof,thepartiesagreethatsuchdisputeshallbe resolved  by  final  and  binding  arbitration  before  a  single  arbitrator  in  Los  Angeles,  CA, administered  by  the  American  Arbitration  Association  (the  AAA),  in  accordance  with AAAsEmploymentADRRules.Thearbitratorsdecisionshallbefinalandbindingupon the parties, and may be entered and enforced in any court of competent jurisdiction by either oftheparties.Thearbitratorshallhavethepowertogranttemporary,preliminaryand permanent relief, including without limitation, injunctive relief and specific performance. b.   TheCompanywillpaythedirectcostsandexpensesofthearbitration,includingarbitration andarbitratorfees.   Exceptasotherwiseprovidedbystatute,ExecutiveandtheCompany are responsible for their respective attorneys fees incurred in connection with enforcing this Agreement.ExecutiveandtheCompanyagreethat,totheextentpermittedbylaw,the arbitratormay,inhisorherdiscretion,awardreasonableattorneysfeestotheprevailing party. 20.MISCELLANEOUS a.If any provision of this Agreement shall be declared, by a court of competent jurisdiction, to beinvalid,illegalorincapableofbeingenforcedinwholeorinpart,theremaining conditionsandprovisionsorportionsthereofshallneverthelessremaininfullforceand effectandenforceabletotheextenttheyarevalid,legalandenforceable,andnoprovision shall be deemed dependent upon any covenant or provision so expressed herein. b.   Thepartiesheretohavemadenoagreements,representationsorwarrantiesrelatingtothe subjectmatterofthisAgreementwhicharenotsetforthherein.Theprovisionsofthis Agreement  may  not  be  amended,  supplemented,  waived,  or  changed  orally,  but  only  in writingandsignedbythepartyastowhomenforcementofanysuchamendment, supplement,waiver,ormodificationissoughtandmakingspecificreferencetothis Agreement. c.Therights,benefits,dutiesandobligationsunderthisAgreementshallinureto,andbe binding  upon,  the  Company,  its  successors  and  assigns,  and  upon  MJ  Management,  its successorsandassigns,andtheExecutiveandherlegalrepresentatives,heirsandlegatees. TheperformanceoftheExecutivesobligationshereundermaynotbetransferredor assigned by MJ Management or the Executive. d.The  failure  of  either  party  to  insist  upon  the  strict  performance  of  any  of  the  terms, conditionsandprovisionsofthisAgreementshallnotbeconstruedasawaiveror relinquishmentoffuturecompliancetherewith,andsaidterms,conditionsandprovisions shallremaininfullforceandeffect.NowaiverofanytermorconditionofthisAgreement, onthepartofeitherparty,shallbeeffectiveforanypurposewhatsoeverunlesssuchwaiver is in writing and signed by such party. e.This Agreement shall be construed and governed by the laws of the State of California.   Parallax Health Sciences, Inc. Executive Agreement  Calli R. Bucci Page 1 of 10  IN WITNESS WHEREOF, this Executive Agreement is dated as of the date first written above. On Behalf of the Company: PARALLAX HEALTH SCIENCES, INC. By:/s/ Paul R. Arena  Paul R. Arena Chief Executive Officer On Behalf of the Executive MJ MANAGEMENT SERVICES, INC. By:/s/ Calli R. Bucci  Calli R. Bucci Executive   Parallax Health Sciences, Inc. Executive Agreement  Calli R. Bucci Page 1 of 10